 | • レポートコード：MRC2-11QY12549 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺がん診断のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他）市場規模、用途別（産業、医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺がん診断の競争状況、市場シェア ・世界の肺がん診断市場：種類別市場規模 2015年-2020年（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他） ・世界の肺がん診断市場：種類別市場規模予測 2021年-2026年（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他） ・世界の肺がん診断市場：用途別市場規模 2015年-2020年（産業、医療、その他） ・世界の肺がん診断市場：用途別市場規模予測 2021年-2026年（産業、医療、その他） ・北米の肺がん診断市場分析：米国、カナダ ・ヨーロッパの肺がん診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺がん診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺がん診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺がん診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、BioMérieux、Qiagen、Advpharma、AIT Austrian Institute of Technology、Courtagen Life Sciences、DiagnoCure、BioMark Diagnostics、Mayo Clinic、HalioDx SAS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
As people’s awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
Market Analysis and Insights: Global Lung Cancer Diagnostics Market
The global Lung Cancer Diagnostics market size is projected to reach US$ 1998.9 million by 2026, from US$ 1883.5 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Lung Cancer Diagnostics Scope and Market Size
Lung Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
BioMérieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Market segment by Type, the product can be split into
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Market segment by Application, split into
Industrial
Healthcare
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunoassays
1.4.3 Flow Cytometry
1.4.4 Rapid Tests
1.4.5 Molecular Assays
1.4.6 Tissue Arrays
1.4.7 Circulating Tumor Cells
1.4.8 Pharmacodiagnostics
1.4.9 Biomarkers
1.4.10 Other
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Industrial
1.5.3 Healthcare
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnostics Market Perspective (2015-2026)
2.2 Global Lung Cancer Diagnostics Growth Trends by Regions
2.2.1 Lung Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostics Players by Market Size
3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Diagnostics Market Concentration Ratio
3.2.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2019
3.3 Lung Cancer Diagnostics Key Players Head office and Area Served
3.4 Key Players Lung Cancer Diagnostics Product Solution and Service
3.5 Date of Enter into Lung Cancer Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Diagnostics Market Size by Application (2015-2020)
5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Diagnostics Market Size (2015-2020)
6.2 Lung Cancer Diagnostics Key Players in North America (2019-2020)
6.3 North America Lung Cancer Diagnostics Market Size by Type (2015-2020)
6.4 North America Lung Cancer Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Diagnostics Market Size (2015-2020)
7.2 Lung Cancer Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Diagnostics Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Diagnostics Market Size (2015-2020)
8.2 Lung Cancer Diagnostics Key Players in China (2019-2020)
8.3 China Lung Cancer Diagnostics Market Size by Type (2015-2020)
8.4 China Lung Cancer Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Diagnostics Market Size (2015-2020)
9.2 Lung Cancer Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Diagnostics Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Diagnostics Market Size (2015-2020)
10.2 Lung Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Diagnostics Market Size (2015-2020)
11.2 Lung Cancer Diagnostics Key Players in India (2019-2020)
11.3 India Lung Cancer Diagnostics Market Size by Type (2015-2020)
11.4 India Lung Cancer Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Diagnostics Market Size (2015-2020)
12.2 Lung Cancer Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
13.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 BioMérieux
13.2.1 BioMérieux Company Details
13.2.2 BioMérieux Business Overview
13.2.3 BioMérieux Lung Cancer Diagnostics Introduction
13.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.2.5 BioMérieux Recent Development
13.3 Qiagen
13.3.1 Qiagen Company Details
13.3.2 Qiagen Business Overview
13.3.3 Qiagen Lung Cancer Diagnostics Introduction
13.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.3.5 Qiagen Recent Development
13.4 Advpharma
13.4.1 Advpharma Company Details
13.4.2 Advpharma Business Overview
13.4.3 Advpharma Lung Cancer Diagnostics Introduction
13.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.4.5 Advpharma Recent Development
13.5 AIT Austrian Institute of Technology
13.5.1 AIT Austrian Institute of Technology Company Details
13.5.2 AIT Austrian Institute of Technology Business Overview
13.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
13.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.5.5 AIT Austrian Institute of Technology Recent Development
13.6 Courtagen Life Sciences
13.6.1 Courtagen Life Sciences Company Details
13.6.2 Courtagen Life Sciences Business Overview
13.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
13.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.6.5 Courtagen Life Sciences Recent Development
13.7 DiagnoCure
13.7.1 DiagnoCure Company Details
13.7.2 DiagnoCure Business Overview
13.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
13.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.7.5 DiagnoCure Recent Development
13.8 BioMark Diagnostics
13.8.1 BioMark Diagnostics Company Details
13.8.2 BioMark Diagnostics Business Overview
13.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
13.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.8.5 BioMark Diagnostics Recent Development
13.9 Mayo Clinic
13.9.1 Mayo Clinic Company Details
13.9.2 Mayo Clinic Business Overview
13.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
13.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.9.5 Mayo Clinic Recent Development
13.10 HalioDx SAS
13.10.1 HalioDx SAS Company Details
13.10.2 HalioDx SAS Business Overview
13.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
13.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2015-2020)
13.10.5 HalioDx SAS Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lung Cancer Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Diagnostics Revenue
Table 3. Ranking of Global Top Lung Cancer Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunoassays
Table 6. Key Players of Flow Cytometry
Table 7. Key Players of Rapid Tests
Table 8. Key Players of Molecular Assays
Table 9. Key Players of Tissue Arrays
Table 10. Key Players of Circulating Tumor Cells
Table 11. Key Players of Pharmacodiagnostics
Table 12. Key Players of Biomarkers
Table 13. Key Players of Other
Table 14. Global Lung Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Lung Cancer Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Lung Cancer Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Lung Cancer Diagnostics Market Share by Regions (2015-2020)
Table 18. Global Lung Cancer Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Lung Cancer Diagnostics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Lung Cancer Diagnostics Market Growth Strategy
Table 24. Main Points Interviewed from Key Lung Cancer Diagnostics Players
Table 25. Global Lung Cancer Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Lung Cancer Diagnostics Market Share by Players (2015-2020)
Table 27. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2019)
Table 28. Global Lung Cancer Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Lung Cancer Diagnostics Product Solution and Service
Table 31. Date of Enter into Lung Cancer Diagnostics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Lung Cancer Diagnostics Market Size Share by Type (2015-2020)
Table 35. Global Lung Cancer Diagnostics Revenue Market Share by Type (2021-2026)
Table 36. Global Lung Cancer Diagnostics Market Size Share by Application (2015-2020)
Table 37. Global Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Lung Cancer Diagnostics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 41. North America Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 43. North America Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 45. Europe Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 47. Europe Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 49. Europe Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 51. China Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 53. China Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. China Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 55. China Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. China Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 57. Japan Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 59. Japan Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 61. Japan Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 65. Southeast Asia Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 67. Southeast Asia Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 69. India Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 71. India Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. India Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 73. India Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. India Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Lung Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Lung Cancer Diagnostics Market Share (2019-2020)
Table 77. Central & South America Lung Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Lung Cancer Diagnostics Market Share by Type (2015-2020)
Table 79. Central & South America Lung Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Lung Cancer Diagnostics Market Share by Application (2015-2020)
Table 81. Roche Diagnostics Company Details
Table 82. Roche Diagnostics Business Overview
Table 83. Roche Diagnostics Product
Table 84. Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 85. Roche Diagnostics Recent Development
Table 86. BioMérieux Company Details
Table 87. BioMérieux Business Overview
Table 88. BioMérieux Product
Table 89. BioMérieux Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 90. BioMérieux Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Product
Table 94. Qiagen Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 95. Qiagen Recent Development
Table 96. Advpharma Company Details
Table 97. Advpharma Business Overview
Table 98. Advpharma Product
Table 99. Advpharma Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 100. Advpharma Recent Development
Table 101. AIT Austrian Institute of Technology Company Details
Table 102. AIT Austrian Institute of Technology Business Overview
Table 103. AIT Austrian Institute of Technology Product
Table 104. AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 105. AIT Austrian Institute of Technology Recent Development
Table 106. Courtagen Life Sciences Company Details
Table 107. Courtagen Life Sciences Business Overview
Table 108. Courtagen Life Sciences Product
Table 109. Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 110. Courtagen Life Sciences Recent Development
Table 111. DiagnoCure Company Details
Table 112. DiagnoCure Business Overview
Table 113. DiagnoCure Product
Table 114. DiagnoCure Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 115. DiagnoCure Recent Development
Table 116. BioMark Diagnostics Business Overview
Table 117. BioMark Diagnostics Product
Table 118. BioMark Diagnostics Company Details
Table 119. BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 120. BioMark Diagnostics Recent Development
Table 121. Mayo Clinic Company Details
Table 122. Mayo Clinic Business Overview
Table 123. Mayo Clinic Product
Table 124. Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 125. Mayo Clinic Recent Development
Table 126. HalioDx SAS Company Details
Table 127. HalioDx SAS Business Overview
Table 128. HalioDx SAS Product
Table 129. HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2015-2020) (Million US$)
Table 130. HalioDx SAS Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Immunoassays Features
Figure 3. Flow Cytometry Features
Figure 4. Rapid Tests Features
Figure 5. Molecular Assays Features
Figure 6. Tissue Arrays Features
Figure 7. Circulating Tumor Cells Features
Figure 8. Pharmacodiagnostics Features
Figure 9. Biomarkers Features
Figure 10. Other Features
Figure 11. Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2026
Figure 12. Industrial Case Studies
Figure 13. Healthcare Case Studies
Figure 14. Other Case Studies
Figure 15. Lung Cancer Diagnostics Report Years Considered
Figure 16. Global Lung Cancer Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Lung Cancer Diagnostics Market Share by Regions: 2020 VS 2026
Figure 18. Global Lung Cancer Diagnostics Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Lung Cancer Diagnostics Market Share by Players in 2019
Figure 21. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2019
Figure 23. North America Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Lung Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 肺がんリキッドバイオプシーの世界市場（～2026年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…
- 肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…